Manuel Collado Rodríguez

Manuel Collado is a CNB-CSIC investigator temporarily established at CiMUS, the Molecular Medicine and Chronic Disease Research Center of USC, and also part of the Health Research Institute of Santiago de Compostela (IDIS). He leads the Cell Senescence, Cancer and Aging Laboratory since 2012. We will be moving shortly to CiMUS premises.

Manuel obtained his PhD at UAM in Madrid in 1997 for work done at CNB-CSIC and was a postdoctoral student, first at the Ludwig Institute for Cancer Research in London, UK, and later at NYU Medical School and at Memorial Sloan Kettering Cancer Center in New York, USA. He returned to Madrid, Spain, in 2001 to join Manuel Serrano´s group at CNB. The laboratory moved in 2003 to the Spanish National Cancer Research Centre (CNIO), where he worked for almost 9 years as staff scientist.

During his career, he has published close to 80 papers, several of them in high impact journal such as Nature (3 articles), Cell, Cancer Cell, Cell Stem Cell, PNAS, EMBO J, Genes & Development, Nature Communications, Aging Cell, Cancer Research, etc. He is also the author of some the most cited reviews in his field published in Nature Reviews Cancer (2 reviews) and Cell (3 reviews).

Along the years, his scientific work has been mainly focused on cancer and in particular tumor suppression mechanisms, working primarily on cell senescence. On this subject he has published more than 30 articles, among them the first in vivo description of oncogene-induced senescence in Nature (more than 1000 citations) or the identification of programmed cell senescence during embryo development, and more recently the description of a new family of senolytic compounds, the Cardiac Glycosides (Nature Communications).